Cargando…
The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study
BACKGROUND: Tuberculosis is a major global public health concern. Patients with tuberculosis who require critical care have a high mortality and delay in initiating antituberculous therapy is associated with increased mortality. Lipoarabinomannan (LAM) is a lipopolysaccharide found in the cell wall...
Autores principales: | de Vasconcellos, Kim, Ramjathan, Praksha, Singh, Dhivendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980562/ https://www.ncbi.nlm.nih.gov/pubmed/33740905 http://dx.doi.org/10.1186/s12879-021-05979-y |
Ejemplares similares
-
1496. Utility of Urinary Lipoarabinomannan (LAM) for Diagnosis of Tuberculosis in HIV-infected Hospitalized Patients – A Prospective Observational Study.
por: Kumar, Deepak, et al.
Publicado: (2023) -
A Sensitive Urinary Lipoarabinomannan Test for Tuberculosis
por: Hamasur, Beston, et al.
Publicado: (2015) -
Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?
por: Flores, Julio, et al.
Publicado: (2021) -
Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
por: Nicol, Mark P, et al.
Publicado: (2014) -
Biomarkers for tuberculosis: the case for lipoarabinomannan
por: Correia-Neves, Margarida, et al.
Publicado: (2019)